Journal of Virus Eradication (Dec 2022)
PP 8.1 – 00003 Optimization of the 5′ cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART
- W. Omange,
- B. Varco-Merth,
- A. Morenco,
- M.T. Chaunzwa,
- C. Nkoy,
- D. Duell,
- O. Fadeyi,
- M. Medina,
- S. Hoffmeister,
- W. Goodwin,
- R. Butler,
- Z. Etaki,
- H. Park,
- J. Smedley,
- M.K. Axhelm,
- S. Hansen,
- J. Lifson,
- J. Gergen,
- S. Rauch,
- B. Petsch,
- L.J. Picker,
- A.A. Okoye
Affiliations
- W. Omange
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA
- B. Varco-Merth
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- A. Morenco
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- M.T. Chaunzwa
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- C. Nkoy
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- D. Duell
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- O. Fadeyi
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- M. Medina
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- S. Hoffmeister
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- W. Goodwin
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- R. Butler
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- Z. Etaki
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- H. Park
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- J. Smedley
- Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- M.K. Axhelm
- Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- S. Hansen
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- J. Lifson
- AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA
- J. Gergen
- CureVac AG, Tübingen, Germany
- S. Rauch
- CureVac AG, Tübingen, Germany
- B. Petsch
- CureVac AG, Tübingen, Germany
- L.J. Picker
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- A.A. Okoye
- Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA
- Journal volume & issue
-
Vol. 8
p. 100281